PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
11-Apr-2024 AbbVie’s AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults AbbVie
10-Apr-2024 Axoltis Pharma receives authorization to launch SEALS – phase II clinical trial for ALS patients with drug candidate NX210c Andrew Lloyd Associates
09-Apr-2024 Green Elephant Biotech expands sustainable 96-well plate line for light-sensitive experiments Green Elephant Biotech
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead Sciences, Inc
09-Apr-2024 Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors Mestag Therapeutics
09-Apr-2024 EpiBiologics Extracellular Protein Degraders Demonstrate Robust Preclinical Anti-tumor Activity and Survival Benefit EpiBiologics
09-Apr-2024 Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD Lundbeck
09-Apr-2024 Bios Health Group Unveils Bios Innovation Circle™ Bios Health Group
09-Apr-2024 GSK’s Jemperli▼ (dostarlimab) is accepted for use within NHS Scotland, in line with its licence, in eligible endometrial cancer patients in first line setting GSK
09-Apr-2024 Veklury (remdesivir) recommended by NICE for treatment of COVID-19 in vulnerable adults and children Gilead Sciences
09-Apr-2024 KITE TO PRESENT COMPARISON OF OUTCOMES OF TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) FROM THE PIVOTAL ZUMA-2 TRIAL VERSUS THE EBMT REGISTRY OF ALLOSCT PATIENTS IN MANTLE CELL LYMPHOMA (MCL) AT 50TH EBMT 2024 KITE
09-Apr-2024 OncoZenge Appoints Åsa Nilsson as Clinical Research Manager OncoZenge
09-Apr-2024 Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma Andrew Lloyd Associates
09-Apr-2024 Companion Diagnostics: Tailoring Treatment for Individual Patients Markets and Markets
08-Apr-2024 InnoScot Health spinout looks to further catalyse growth with London conference slot InnoScot Health
08-Apr-2024 AACR 2024: PDC*line Pharma presents interim clinical results from last cohort of patients in phase I/II trial with PDC*lung01 cancer vaccine Andrew Lloyd Associates
05-Apr-2024 FDA Accepts Supplemental Biologics License Applications for BIMZELX® (bimekizumab-bkzx) for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations UCB
05-Apr-2024 MRNA CMC HARMONIZATION, MANUFACTURING & ANALYTICAL TO BE DISCUSSED BY VERNAL EXPERTS AT INDUSTRY CONFERENCES Vernal Biosciences
05-Apr-2024 Chiesi’s carbon minimal inhalers reach innovation milestone as phase III trials now underway Chiesi Group
05-Apr-2024 PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab PolTREG